| Section | Status | BlueTeq | Name |
| 08.02 | Formulary |  |
Acalabrutinib Calquence® |
| 08.02.03 | Restricted Use | |
Brentuximab vedotin Adcetris® |
| 08.02 | Formulary | |
Brigatinib Alunbrig® |
| 08.02.03 | Formulary | |
Daratumumab Darzalex® |
| 08.02 | Formulary | |
Gilteritinib Xospata® |
| 08.02.03 | Restricted Use | |
Isatuximab Sarclisa® |
| 08.01 | Non Formulary | |
Lorlatinib Lorviqua® |
| 08.02 | Formulary | |
Lorlatinib Lorviqua® |
| 08.02 | Formulary | |
Niraparib Zejula® |
| 03.04.02 | Restricted Use | |
Omalizumab Xolair® |
| 08.02 | Formulary | |
Osimertinib Tagrisso® |
| 08.02.03 | Restricted Use | |
Polatuzumab vedotin Polivy® |
| 05.03 | Restricted Use | |
Remdesivir |
| 08.02 | Formulary | |
Rucaparib Rubraca® |
| 08.02 | Formulary | |
Venetoclax Venclyxto® |